FluoroPharma Medical Company Profile (OTCMKTS:FPMI)

About FluoroPharma Medical (OTCMKTS:FPMI)

FluoroPharma Medical logoFluoroPharma Medical, Inc., formerly Commercial E-Waste Management Inc., is a biopharmaceutical company specializing in discovering, developing and commercializing molecular imaging pharmaceuticals with applications in the area of cardiology. The Company operates through biopharmaceutical research and development segment. It is focused on the development of cardiovascular imaging agents that can detect and assess acute and chronic forms of coronary artery disease (CAD). It has two clinical-stage molecular imaging pharmaceutical product candidates: Flourine-18 (18-F) TPP (BFPET), which includes a ((18F)-labeled cationic lipophilic tetraphenylphosphonium ion (18-F TPP) as an imaging agent designed for use in stress-testing for patients with presumptive or proven CAD, and 18-F FCPHA (CardioPET), which includes Trans-9-(18F)-Fluoro-3, 4-Methyleneheptadecanoic Acid (18-F FCPHA) as a molecular imaging agent designed to assess myocardial blood flow and metabolism in patients with CAD.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: OTCMKTS:FPMI
  • CUSIP: N/A
  • Web: www.fluoropharma.com
  • Market Cap: $1.03 million
  • Outstanding Shares: 34,262,000
Average Prices:
  • 50 Day Moving Avg: $0.04
  • 200 Day Moving Avg: $0.07
  • 52 Week Range: $0.02 - $0.29
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.000
Sales & Book Value:
  • Annual Revenue: N/A
  • Price / Sales: N/A
  • Book Value: ($0.30) per share
  • Price / Book: -0.09
  • EBIDTA: ($2,160,000.00)
  • Return on Assets: -608.29%
  • Average Volume: 34,473 shs.
  • Beta: 0.75
Frequently Asked Questions for FluoroPharma Medical (OTCMKTS:FPMI)

What is FluoroPharma Medical's stock symbol?

FluoroPharma Medical trades on the OTCMKTS under the ticker symbol "FPMI."

How were FluoroPharma Medical's earnings last quarter?

FluoroPharma Medical Inc. (OTCMKTS:FPMI) announced its earnings results on Friday, August, 14th. The company reported ($0.05) EPS for the quarter, topping the Zacks' consensus estimate of ($0.06) by $0.01. View FluoroPharma Medical's Earnings History.

Who are some of FluoroPharma Medical's key competitors?

Who are FluoroPharma Medical's key executives?

FluoroPharma Medical's management team includes the folowing people:

  • Walter W. Witoshkin, Interim Chairman of the Board, Independent Director
  • Thomas H. Tulip Ph.D., President, Chief Executive Officer, Director
  • Tamara Rhein, Chief Financial Officer
  • W. Austin Lewis IV, Director

How do I buy FluoroPharma Medical stock?

Shares of FluoroPharma Medical can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is FluoroPharma Medical's stock price today?

One share of FluoroPharma Medical stock can currently be purchased for approximately $0.03.

MarketBeat Community Rating for FluoroPharma Medical (OTCMKTS FPMI)
Community Ranking:  3.3 out of 5 (  )
Outperform Votes:  2 (Vote Outperform)
Underperform Votes:  1 (Vote Underperform)
Total Votes:  3
MarketBeat's community ratings are surveys of what our community members think about FluoroPharma Medical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for FluoroPharma Medical (OTCMKTS:FPMI) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for FluoroPharma Medical (OTCMKTS:FPMI)
No equities research coverage for this company has been tracked by MarketBeat.com


Earnings History for FluoroPharma Medical (OTCMKTS:FPMI)
Earnings by Quarter for FluoroPharma Medical (OTCMKTS:FPMI)
Earnings History by Quarter for FluoroPharma Medical (OTCMKTS FPMI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/14/2015Q2 2015($0.06)($0.05)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for FluoroPharma Medical (OTCMKTS:FPMI)

No earnings estimates for this company have been tracked by MarketBeat.com


Dividend History for FluoroPharma Medical (OTCMKTS:FPMI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for FluoroPharma Medical (OTCMKTS:FPMI)
Insider Ownership Percentage: 36.90%
Insider Trades by Quarter for FluoroPharma Medical (OTCMKTS:FPMI)
Insider Trades by Quarter for FluoroPharma Medical (OTCMKTS:FPMI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/7/2014Johan M SpoorCEOBuy10,000$0.50$5,000.00View SEC Filing  
11/26/2012Johan M SpoorCEOBuy10,000$0.76$7,600.00View SEC Filing  
9/12/2012Johan M SpoorCEOBuy50,000$0.80$40,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for FluoroPharma Medical (OTCMKTS:FPMI)
Latest Headlines for FluoroPharma Medical (OTCMKTS:FPMI)



FluoroPharma Medical (FPMI) Chart for Tuesday, July, 25, 2017

This page was last updated on 7/25/2017 by MarketBeat.com Staff